European AstraZeneca debacle: mismanagement, misinformation and vaccine diplomacy
A number of countries in Europe halted the use of the AstraZeneca/Oxford University vaccine over the past two weeks, due to an unproven association with blood clots. Following a review by the European Medical Agency, they have now resumed, but this politically driven decision has seriously dented public confidence in the vaccine, which was already low.